Category Filter
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HealthSmartRx Smart RxAssist Program
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pharmacy
- Pre-Service Review (Precertification and Predetermination)
- Pre-Service Review (Precertification/Predetermination)
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Provider-Administered Oncology Drugs
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Asset Publisher
Content with Policies & Guidelines Final Provider-Administered Oncology Drugs .
print
Print
Back
Back
Kymriah (tisagenlecleucel) (Intravenous)
Policy Number: VP-0319
Intravenous
...
print
Print
Back
Back
Yescarta™ (axicabtagene ciloleucel) (Intravenous)
Policy Number: VP-0333
...
print
Print
Back
Back
Tecartus™ (brexucabtagene autoleucel) (Intravenous)
Policy Number: VP-0558
...
print
Print
Back
Back
Breyanzi® (lisocabtagene maraleucel) (Intravenous)
Policy Number: VP-0590
...
print
Print
Back
Back
Abecma® (idecabtagene vicleucel) (Intravenous)
Policy Number: VP-0598
...
print
Print
Back
Back
Carvykti™ (ciltacabtagene autoleucel) (Intravenous)
Policy Number: VP-0663
...
print
Print
Back
Back
Adstiladrin® (nadofaragene firadenovec-vncg) (Intravesical)
Policy Number: VP-0691
Last...